Home LiteratureArticle Details
PMID: 2840551 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Plasmid origin of replication of Epstein-Barr virus, oriP, does not limit replication in cis.

Molecular biology & medicine ·Vol. 5 ·No. 2 ·1988-04-00 ·Pages 85-94

Sugden B, Warren N

Abstract

Two plasmids encoding resistance to hygromycin-B or to the analog of neomycin, G418, and containing either one or two copies of the plasmid origin of replication, oriP, of Epstein-Barr virus (EBV) were introduced into an EBV-positive B-lymphoblastoid cell line. Two clones of cells containing both plasmids were analyzed for the number of copies of each plasmid when the cells were propagated in the absence or in the presence of one or both selective agents. Under all conditions tested, the plasmid with two copies of oriP behaved in cells as did the plasmid with one copy of this plasmid origin of replication.

MeSH Terms
B-Lymphocytes Burkitt Lymphoma/pathology DNA, Recombinant DNA, Viral/genetics Gene Expression Regulation Genes, Viral Herpesvirus 4, Human/genetics,physiology Plasmids Tumor Cells, Cultured/analysis Virus Replication
Chemicals
DNA, Recombinant DNA, Viral
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Sugden B
McArdle Laboratory for Cancer Research, University of Wisconsin-Madison 53706.
Warren N
Article Info
Journal
Molecular biology & medicine
Abbr.
Mol Biol Med
ISSN
0735-1313
Published
1988-04-00
Pages
85-94
Language
English
Region
England
NLM ID
8403879
Subset
IM
Grants
NCI NIH HHS · CA-07175 · United States
NCI NIH HHS · CA-22443 · United States
External Links
PubMed source
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]